Avg closing price
Price range

2 Stanley Druckenmiller Recursion Pharmaceuticals Trades

Stanley Druckenmiller acquired 274 Thousand Recursion Pharmaceuticals shares worth $3.21 Million. That's 0.22% of their equity portfolio (29th largest holding). The investor's estimated purchase price is $7.51 Million, resulting in a loss of 57%.

Avg closing price
Price range
Increased shares by 5.3% (+13.7 Thousand shares) Q1 2022
Avg closing price $10.63
Price range $6.16 - $18.03
New holding (+260 Thousand shares) Q3 2021
Avg closing price $28.34
Price range $19.03 - $41.33

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!